Suppr超能文献

中国类风湿关节炎患者的HLA - DRB1等位基因分型

HLA-DRB1 alleles genotyping in patients with rheumatoid arthritis in Chinese.

作者信息

Zhao Y, Dong Y, Zhu X, Qiu C

机构信息

National Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, CAMS, Beijing.

出版信息

Chin Med Sci J. 1996 Dec;11(4):232-5.

PMID:9387389
Abstract

OBJECTIVE

To explore the role of HLA-DRB1 genes in the development of rheumatoid arthritis (RA) and the correlations between HLA-DR alleles and clinical manifestations of patients with RA.

METHODS

86 patients with rheumatoid arthritis and 106 race matched controls were studied in whom HLA-DR typing was performed by the method of DNA amplification with sequence-specific primers (PCR-SSP). The subtypes of HLA-DR4 were determined by the method of hybridization of PCR products with sequence-specific oligonucleotides (PCR-SSO). The absence or presence of HLA-DR4 and its subtypes was correlated with the clinical and serological characteristics of the patients.

RESULTS

Compared with controls, an increased gene frequency of HLA-DR4 (48.8% vs 17.9%, P < 0.001) and a decreased frequency of HLA-DR7 (16.3% vs 27.4%, P = 0.06) were found. The DRB1* 0405 account for 61.9% of DR4+RA patients and 21.1% of DR4+ controls (P < 0.01). There was no difference between the DR4+ and DR4- patients with respect to age, sex, duration of disease, rheumatoid factor (RF), extra-articular manifestations including secondary Sjogren's syndrome. According to the wrist X-ray stage, the patients of DR4+ were more severe than that of DR4- (P < 0.05).

CONCLUSION

HLA-DR4 and DR4 subtype of DRB1*0405 are related to the development of RA in Chinese. HLA-DR4 can be a useful prognostic marker in the patients with RA.

摘要

目的

探讨人类白细胞抗原-DRB1(HLA-DRB1)基因在类风湿关节炎(RA)发病中的作用以及HLA-DR等位基因与RA患者临床表现之间的相关性。

方法

对86例类风湿关节炎患者和106例种族匹配的对照者进行研究,采用序列特异性引物DNA扩增法(PCR-SSP)进行HLA-DR分型。通过PCR产物与序列特异性寡核苷酸杂交法(PCR-SSO)确定HLA-DR4的亚型。分析HLA-DR4及其亚型的有无与患者临床和血清学特征的相关性。

结果

与对照组相比,发现HLA-DR4基因频率升高(48.8%对17.9%,P<0.001),HLA-DR7基因频率降低(16.3%对27.4%,P=0.06)。DRB1*0405在DR4+RA患者中占61.9%,在DR4+对照者中占21.1%(P<0.01)。DR4+和DR4-患者在年龄、性别、病程、类风湿因子(RF)、包括继发性干燥综合征在内的关节外表现方面无差异。根据腕关节X线分期,DR4+患者比DR4-患者病情更严重(P<0.05)。

结论

HLA-DR4及DRB1*0405的DR4亚型与中国人群RA的发病有关。HLA-DR4可作为RA患者有用的预后标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验